Jonathan Bestwick

Jonathan Bestwick is a Senior Lecturer in Medical Statistics at Queen Mary University of London's Wolfson Institute of Population Health. He specializes in medical screening and neurodegenerative disease epidemiology, with a focus on Parkinson's Disease, familial hypercholesterolemia, and cardiovascular disease. His work bridges statistical methodology with clinical research in large-scale studies, including the PREDICT-PD trial.

• Education: BSc in Mathematics and Statistics from Imperial College London (1999-2002); MSc in Medical Statistics from University of Leicester (2002-2003)
• Affiliation: Centre for Preventive Neurology and Centre for Prevention, Detection and Diagnosis

His research spans prenatal screening for Down syndrome and pre-eclampsia to modern neurodegenerative disease detection. Recent publications analyze Parkinson's olfactory dysfunction, digital health interventions, and neuroimmunology clinical trials. He also serves as statistical advisor on the Journal of Medical Screening editorial board and leads undergraduate teaching modules in Public Health.

Article trends include neurodegenerative epidemiology (Parkinson's/Alzheimer's), cardiovascular screening innovations (polypill/FABULAS trial), and digital health applications. Subfields encompass medical technology validation, clinical trial design, and cross-cultural dementia risk modeling.

Teaching roles:

• Undergraduate Teaching Lead for Wolfson Institute
• Co-Lead for Year 2 MBBS Human Science and Public Health module
• Lead for Year 3 MBBS Public Health module